Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Research Square
|
September 2, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer
Leigh Ellis, Beatriz German, Katherine Morel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
Susan Halabi, Akash Roy, Larysa Rydzewska, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2019
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology
Roberto Salgado, David B Solit, David L Rimm, et al.
European Urology
|
February 25, 2018
Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies
Gwenaelle Gravis, Jean-Marie Boher, Yu-Hui Chen, et al.
Nature
|
December 2, 2016
Genomic evolution and chemoresistance in germ-cell tumours
Amaro Taylor-Weiner, Travis Zack, Elizabeth O'Donnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2021
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
Jonathan E Rosenberg, Karla A Ballman, Susan Halabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2014
SPINK1 protein expression and prostate cancer progression
Richard Flavin, Andreas Pettersson, Whitney K Hendrickson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy
Angelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
British Journal of Cancer
|
September 30, 2023
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database
Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial
David C Smith, Matthew R Smith, Christopher Sweeney, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Research Square
|
September 2, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer
Leigh Ellis, Beatriz German, Katherine Morel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
Susan Halabi, Akash Roy, Larysa Rydzewska, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2019
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology
Roberto Salgado, David B Solit, David L Rimm, et al.
European Urology
|
February 25, 2018
Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies
Gwenaelle Gravis, Jean-Marie Boher, Yu-Hui Chen, et al.
Nature
|
December 2, 2016
Genomic evolution and chemoresistance in germ-cell tumours
Amaro Taylor-Weiner, Travis Zack, Elizabeth O'Donnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2021
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
Jonathan E Rosenberg, Karla A Ballman, Susan Halabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2014
SPINK1 protein expression and prostate cancer progression
Richard Flavin, Andreas Pettersson, Whitney K Hendrickson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy
Angelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
British Journal of Cancer
|
September 30, 2023
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database
Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial
David C Smith, Matthew R Smith, Christopher Sweeney, et al.
Page
of 9